Figma slides as traders refocus on looming extended lock-up share release window
Figma shares fell about 3% to $20.51 as investors focused on potential near-term share-supply pressure tied to the company’s extended lock-up schedule. The extended lock-up agreement allows up to ~61.1 million shares to be released starting the second trading day after Figma reports results for the quarter ending March 31, 2026.
1) What’s moving the stock
Figma (FIG) traded lower today, with the decline aligning with renewed focus on the company’s post-IPO share-supply overhang. Market participants have been tracking the company’s extended lock-up structure, which can add meaningful incremental float at defined milestones, pressuring the stock when investors anticipate additional shares becoming sale-eligible.
2) The catalyst traders are watching: extended lock-up mechanics
Figma disclosed that the extended lock-up agreement covering large holders includes staged releases tied to earnings dates. One key milestone permits up to an additional 27.5% of the extended lock-up holders’ Class A shares (about 61.1 million shares) to be released beginning at the start of trading on the second trading day after the company announces earnings for the quarter ending March 31, 2026—creating a specific window that traders often front-run as a potential supply event.
3) Why it matters at $20–$21
With the stock trading near the low-$20s, even the expectation of incremental float can weigh on price as investors demand a higher risk premium for potential selling pressure. The dynamic is often amplified in growth software names where valuation sensitivity and momentum positioning can drive outsized moves around technical supply-and-demand changes.
4) What to watch next
Investors will be monitoring the Q1 2026 earnings report date, any updates to the lock-up release framework, and evidence of selling intent via filings or trading-plan disclosures. If the next earnings update shifts sentiment on growth and profitability, it could either offset supply concerns or compound them if guidance disappoints.